| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
President
1 company
Juan C. Jaen is President at RCUS. Juan C. Jaen's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $15.5M at current prices.
Our model assigns Juan C. Jaen a strong insider score of 76/100, based on 24 past trades. Over a 12-month horizon, all 11 of those trades were profitable, with an average 12-month return of +23.1%.
The RCUS filings lean toward selling, a net 325,678 shares.
Juan C. Jaen has 34 Form 4 filings on record from March 2018 to July 2026, all as President at Arcus Biosciences (RCUS), 2018–2026.
The 70 reported transactions were 38 open-market sales, 8 option or other derivative awards, 8 open-market purchases and 7 stock awards, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 5 purchases worth about $1.4M and 14 sales worth about $10.3M.
The largest open-market purchase was 66,666 shares of RCUS at an average $15.00 on March 19, 2018, about $1.0M.
The largest open-market sale was 82,997 shares of RCUS at an average $24.71 on December 4, 2025, about $2.1M.
All 10 sales since April 2023 were made under a Rule 10b5-1 trading plan, set up in advance.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | RCUS Arcus Biosciences, Inc. | President | Sell10b5-1 | 68,569 | $29.63 | $2,031,918.79 | -7.7% | -17.6% | - | |
| Jun 24, 2026 | RCUS Arcus Biosciences, Inc. | President | Sell10b5-1 | 31,431 | $27.92 | $877,501.25 | -3.4% | -6.7% | - | |
| Jan 5, 2026 | RCUS Arcus Biosciences, Inc. | President | Sell10b5-1 | 31,823 | $21.41 | $681,341.82 | -3.3% | +2.2% | - | |
| Dec 17, 2025 | RCUS Arcus Biosciences, Inc. | President | Sell10b5-1 | 21,208 | $22.01 | $466,869.56 | -5.8% | +1.4% | - | |
| Dec 4, 2025 | RCUS Arcus Biosciences, Inc. | President | Sell10b5-1 | 82,997 | $24.71 | $2,050,598.58 | -8.0% | -10.2% | - | |
| Nov 18, 2025 | RCUS Arcus Biosciences, Inc. | President | Sell10b5-1 | 50,000 | $20.26 | $1,012,764.29 | -4.6% | -4.7% | - | |
| Oct 30, 2025 | RCUS Arcus Biosciences, Inc. | President | Sell10b5-1 | 4,314 | $20.32 | $87,649.69 | -0.4% | +7.5% | -7.8% | |
| Oct 29, 2025 | RCUS Arcus Biosciences, Inc. | President | Sell10b5-1 | 96,859 | $20.76 | $2,010,578.37 | -8.2% | +13.3% | -8.3% | |
| Feb 27, 2024 | RCUS Arcus Biosciences, Inc. | President | Sell10b5-1 | 27,032 | $20.09 | $543,187.20 | -2.2% | -22.3% | -49.8% | |
| Jan 2, 2024 | RCUS Arcus Biosciences, Inc. | President | Sell10b5-1 | 6,975 | $20.09 | $140,127.75 | -0.6% | -6.1% | -23.1% |